Product Image
Please see full prescribing and safety information, including boxed warning, for MELPHALAN Hydrochloride for Injection.

Available in:

  • 50 mg melphalan, 10 mL sterile diluent kit


  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex

MELPHALAN Hydrochloride for Injection*

Brand Name Equivalent: Alkeran® (Alkeran is a registered trademark of Par Pharmaceutical, Inc.)
Therapeutic Category: Oncology

PreventIV Measures® Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
Description Strength Fill
Concentration Container
Closure Unit
of Sale
258-61 glass vial 50 mg N/A N/A 15 mL 20 mm 1


Melphalan Hydrochloride for Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Severe bone marrow suppression with resulting infection or bleeding may occur. Controlled trials comparing intravenous to oral melphalan have shown more myelosuppression with the intravenous formulation. Hypersensitivity reactions, including anaphylaxis, have occurred in approximately 2% of patients who received the intravenous formulation. Melphalan is leukemogenic in humans. Melphalan produces chromosomal aberrations in vitro and in vivo and, therefore, should be considered potentially mutagenic in humans.